EBM Technologies Incorporated

As of June 30, 2026, EBM Technologies Incorporated carries a market capitalization of 619.20M, placing it among publicly traded companies globally. Its enterprise value stands at 559.64M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, EBM Technologies Incorporated has 32.00M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 3.01, and the price-to-book ratio stands at 2.06.

As of June 30, 2026, EBM Technologies Incorporated trades at an EV/EBITDA multiple of 373.34 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.75 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 559.64M versus a market cap of 619.20M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, EBM Technologies Incorporated maintains a current ratio of 1.57, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 26.18, indicating elevated leverage, while an interest coverage ratio of 0.95 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, EBM Technologies Incorporated posted a negative return on equity (ROE) of -4.64, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.03, reflecting losses generated across the asset base. The company generates approximately 1.41M in revenue per employee across its workforce of 144.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.21 indicates how many times EBM Technologies Incorporated sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, EBM Technologies Incorporated recorded 3.17M in income tax expense. The company reported a pretax loss of -10.50M and -13.67M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, EBM Technologies Incorporated's stock has declined approximately 22.86% over the past 52 weeks. The 50-day moving average sits at 18.13, while the 200-day moving average is 19.64.

Over the twelve months ended June 30, 2026, EBM Technologies Incorporated generated 203.54M in revenue and converted that into -13.67M in net income, yielding earnings per share of -0.43. EBITDA reached 1.50M, while operating income came in at -9.92M.

As of June 30, 2026, EBM Technologies Incorporated holds 138.16M in cash and equivalents against 78.60M in total debt, resulting in a net debt position of -64.87M. Total book value stands at 300.21M, with working capital of 66.43M providing operational flexibility.

EBM Technologies Incorporated produced -32.37M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -2.07M in capital expenditures, free cash flow totaled -34.44M - equivalent to -1.09 per share.

Over the twelve months ended June 30, 2026, EBM Technologies Incorporated posted a gross margin of 78.17, reflecting its pricing power and cost economics. The operating margin of -4.87 and net profit margin of -6.72 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -5.62: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -0.82, meaning EBM Technologies Incorporated raised more capital through share issuance and new debt than it returned via dividends and buybacks.

EBM Technologies Incorporated's most recent stock split took place on June 30, 2021 with a 299:305 split ratio.

As of June 30, 2026, EBM Technologies Incorporated has an Altman Z-Score of 3.36, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.